InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Onconetix, Inc.

ONCO Clue Score34
United States Fiscal year ends December CIK 0001782107
$0.62 -5.24% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.62 +47.62% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 18 Feb 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Operating income−3.4Net income−3.4EPS, diluted−1.26Fiscal year 2022Operating income−13.5Net income−13.4EPS, diluted−1.10Fiscal year 2023Revenue0.1Operating income−36.0Net income−37.4EPS, diluted−87.45Fiscal year 2024Revenue2.5 +4,217.3%Operating income−56.5Net income−58.7EPS, diluted−1,823.39Fiscal year 2025Revenue0.8 −67.7%Operating income−17.9Net income−14.0EPS, diluted−16.56
FY2021FY2022FY2023FY2024FY2025
Revenue n/a n/a 0.1 2.5 0.8
Growth +4,217.3% −67.7%
Operating income −3.4 −13.5 −36.0 −56.5 −17.9
Net income −3.4 −13.4 −37.4 −58.7 −14.0
Growth
EPS, diluted −1.26 −1.10 −87.45 −1,823.39 −16.56

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Fiscal year 2022Fiscal year 2023Gross margin−1,927.9%Operating margin−61,634.5%Net margin−63,986.5%Free cash flow margin−23,235.0%Fiscal year 2024Gross margin41.8%Operating margin−2,238.0%Net margin−2,325.2%Free cash flow margin−416.9%Fiscal year 2025Gross margin77.6%Operating margin−2,190.0%Net margin−1,721.0%
FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a −1,927.9% 41.8% 77.6%
Operating margin n/a n/a −61,634.5% −2,238.0% −2,190.0%
Net margin n/a n/a −63,986.5% −2,325.2% −1,721.0%
Free cash flow margin n/a n/a −23,235.0% −416.9% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−2.0Capital expenditure−0.0Free cash flow−2.0Fiscal year 2022Operating cash flow−8.7Capital expenditure−0.0Free cash flow−8.7Buybacks−0.6Fiscal year 2023Operating cash flow−13.6Capital expenditure−0.0Free cash flow−13.6Fiscal year 2024Operating cash flow−10.5Capital expenditure−0.0Free cash flow−10.5Fiscal year 2025Operating cash flow−9.7
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −2.0 −8.7 −13.6 −10.5 −9.7
Capital expenditure −0.0 −0.0 −0.0 −0.0 n/a
Free cash flow −2.0 −8.7 −13.6 −10.5 n/a
Growth
Buybacks n/a −0.6 n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash1.9Shareholders’ equity1.4Fiscal year 2022Cash25.8Shareholders’ equity22.4Fiscal year 2023Cash4.6Shareholders’ equity−5.6Fiscal year 2024Cash0.6Shareholders’ equity8.5Fiscal year 2025Cash5.2Shareholders’ equity15.8
FY2021FY2022FY2023FY2024FY2025
Cash 1.9 25.8 4.6 0.6 5.2
Shareholders’ equity 1.4 22.4 −5.6 8.5 15.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
n/a n/a −1,927.9% 41.8% 77.6%
n/a n/a −61,634.5% −2,238.0% −2,190.0%
n/a n/a −64,008.0% −2,366.6% −1,720.9%
n/a n/a −63,986.5% −2,325.2% −1,721.0%
n/a n/a −23,235.0% −416.9% n/a
Spending
n/a n/a 3,334.3% 6.1% n/a
n/a n/a 25,264.1% 445.0% 863.9%
n/a n/a 5.6% 1.1% n/a
Returns
−236.2% −59.9% n/a −687.0% −89.0%
−110.8% −51.0% −42.7% −208.3% −56.3%
Balance and payout
53.1% 14.9% 25.0% 65.9% 36.7%